UPC (Universe Pharmaceuticals Inc. Class A Ordinary Shares) Stock Analysis - SEC Filings

Universe Pharmaceuticals Inc. Class A Ordinary Shares (UPC) is a publicly traded Healthcare sector company. As of May 21, 2026, UPC trades at $2.76 with a market cap of $1.45M and a P/E ratio of 0.00. UPC moved +0.00% today. Year to date, UPC is -33.99%; over the trailing twelve months it is -55.22%. Its 52-week range spans $2.00 to $600.00. Rallies surfaces UPC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find UPC SEC filings?

Rallies organizes UPC SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

UPC Key Metrics

Key financial metrics for UPC
MetricValue
Price$2.76
Market Cap$1.45M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.33%
52-Week High$600.00
52-Week Low$2.00
Volume3
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest UPC News

UPC Analyst Consensus

UPC analyst coverage data. Average price target: $0.00.

Common questions about UPC

Where can I find UPC SEC filings?
Rallies organizes UPC SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show UPC 10-K and 10-Q filings?
Rallies organizes UPC SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is UPC research on Rallies investment advice?
No. Rallies provides research, data, and educational context for UPC. It does not provide personalized investment advice.
UPC

UPC